New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes Nov 21, 2008 02:00PM

FRANKLIN LAKES, N.J., Nov. 21 /PRNewswire-FirstCall/ -- Today, prescription drugs are the first choice for medical intervention in treating 88 percent of patients suffering chronic conditions. The 50 percent of Americans treated for a chronic condition account for 96 percent of all prescription drug spending and 75 percent of all medical costs. A proprietary new pharmacy model developed over three years by Medco Health Solutions, Inc. (NYSE: MHS) significantly reduces critical gaps in care for patients with chronic and complex diseases and lowers overall medical costs, according to an independently validated set of analyses released today. "The data could not be more compelling. In an era where we have seen huge increases in the number of patients with chronic disease, an evidence-based protocol model leveraging the Medco Therapeutic Resource Centers(R), has proven critical to improving the effectiveness of treatment and driving down the cost of health care ...


Illinois Technology Industry Index Now Available Nov 20, 2008 11:37AM

CHICAGO--(BUSINESS WIRE)-- First Analysis Securities Corporation (FASC)* and the Illinois Technology Association (ITA) will present a monthly stock index representing the pulse of Illinois based technology companies. The ITA will make this index and analysis available to its members and through their website (www.illinoistech.org) each month. The FASC/ITA Illinois Technology Index is a market capitalization-weighted index of publicly traded stocks in the Illinois technology sector. The index data was calculated starting from May 2006, at which time the index level was standardized to 100. Speaking to ...


LEVEL5 Announces New Market Analysis System for Financial Institutions Nov 18, 2008 08:00AM

ORLANDO, Fla.--(BUSINESS WIRE)-- LEVEL5, a consulting and facilities development firm specializing in financial institutions, announced at the BAI Retail Delivery Conference & Expo the availability of Financial Institution Tool (FIT), an innovative diagnostic tool for financial institutions. FIT compiles and analyzes market data, including trend analysis and forecasting, to help financial institutions make strategic decisions about geographic expansion and which business lines will be most advantageous in new markets. "FIT is the first analysis tool that equips financial institutions with an unbiased, comprehensive comparison of real estate opportunities," ...


GARDASIL(R), Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study Nov 13, 2008 08:00AM

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- GARDASIL(R) (Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant), the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV) types 6, 11, 16 and 18 in a pivotal Phase III study in men aged 16 to 26. These are the only data evaluating efficacy of any HPV vaccine in preventing disease in males, and were presented for the first time this week at the European Research Organization on Genital Infection and Neoplasia (EUROGIN) International Multidisciplinary Conference. The initial planned analysis of this study, an analysis ...


Initiate Systems Fortifies Board with Three New Directors Nov 11, 2008 09:20AM

CHICAGO--(BUSINESS WIRE)-- Initiate Systems, Inc., a leader in master data management (MDM) solutions, announced today that Niloofar Howe, a managing director of Paladin Capital Group, Mike Daniels, a member of the board of directors of Sybase, Inc., and R. Stephen Cheheyl, a former computer, software and data communications executive, have been appointed to the company's Board of Directors. The three additions diversify and deepen the board's experience in the areas of strategic investment and high-tech business management. Howe joined the Initiate Systems board of directors early this year when Paladin invested in Initiate. Howe's current responsibilities at Paladin include developing and implementing new investment opportunities for each of Paladin's funds, including the firm's most recent fund, Paladin III. Prior to joining Paladin, Howe served as Principal at Zone Ventures a Los Angeles-based venture capital firm. She also worked with McKinsey & Company as a strategic consultant ...




Nov 5, 2008 09:03AM Webinar: First Analysis of Voter Views and Motivations
Nov 3, 2008 12:51PM Webinar: First Analysis of Voter Views and Motivations
Nov 3, 2008 11:56AM CDC Releases First Estimate of Human Papillomavirus-Associated Cancer Data
Sep 23, 2008 04:00PM ALGOR FEA Software Certified for Autodesk Inventor 2009 Software on 32- and 64-Bit Systems
Aug 20, 2008 09:54AM First Analysis Upgrades Universal Technical Institute (UTI) to Overweight
Aug 12, 2008 08:59AM First Analysis Downgrades Republic Services (RSG) to Equalweight
Aug 4, 2008 10:56AM First Analysis Downgrades SPSS Inc. (SPSS) to Equal Weight
Jul 31, 2008 08:56AM First Analysis Downgrades Total System Services (TSS) to Equalweight
Jul 18, 2008 09:13AM First Analysis Initiates Coverage on ArcSight (ARST) with an Overweight